Fang Xuhua Elected Vice Chairman of Pu'er Federation of Industry and Commerce
Release time:
2022-06-13
News from our newspaper days ago, Pu'er City Federation of Industry and Commerce (General Chamber of Commerce) held its fifth congress, and Fang Xuhua, executive deputy general manager of Yunnan Jianfeng Cement Company, was elected vice chairman.
Yunnan Peak has rapidly grown into a leading enterprise in the regional market and a major profit and tax owner in Pu'er City since it was completed and put into operation in 2013 , establishing a good corporate image and forming a wide range of social influence. In an interview with local media, Fang Xuhua said that being elected as the vice chairman of the Pu'er City Federation of Industry and Commerce this time is the recognition of Yunnan Jianfeng by the people of Pu'er and the industrial and commercial circles; the rapid development of Yunnan Jianfeng is due to the support of the group company and the efforts of all cadres and employees. It is inseparable from Pu'er's good business environment and the strong support of government departments at all levels. He hopes that government departments at all levels in Pu'er can make more innovations in service awareness, service methods, and service mechanisms for enterprises, and actively and creatively help enterprises solve the pain points, blocking points, and difficult problems in development, and continue to continue Optimize the business environment so that enterprises can invest and develop with confidence; while doing a good job in their own production and operation, Yunnan Peak, it will also make good use of the platform of the Federation of Industry and Commerce to provide support within its capacity for the further optimization and development of the Pu'er regional economy. (Reporter)
Separate News 5# December 13 On the afternoon of the 14th, the Pu 'er Industrial Park Federation of Trade Unions held the 4th "Most Beautiful Workers" and 2022 Outstanding Trade Union Cadres and Outstanding Trade Union Activists Commendation Meeting. Fang Xuhua, party branch secretary and trade union chairman of Yunnan Jianfeng Cement Company, won the honor of "Outstanding Trade Union Cadre" in 2022 in Pu 'er Industrial Park, and Yang Shunchang, an employee of Yunnan Jianfeng Cement Company, was awarded the title of "Outstanding Trade Union Activist" in 2022 in Pu 'er Industrial Park.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31